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Anesthesia
Perioperative effects of oral midazolam premedication in children undergoing skin laser 
treatment. A double-blinded randomized placebo-controlled trial1
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ABSTRACT
Purpose: To investigate and compare the efficacy of oral midazolam with two different dosages in orange juice on perioperative 
hemodynamics and behavioral changes in children who underwent skin laser treatment in an academic educational Hospital. Methods: 
Ninety  children, candidates for skin laser treatment were randomly assigned to 1 of 3 groups of 30 each: the placebo group received 
0.1 ml/kg orange flavored juice, group 2 and 3 receiving 0.5 and 1 mg/kg of injectable midazolam mixed with an equal volume of 
orange juice, respectively. The main outcome measures included the mask acceptance, patients’ behavioral scales and postoperative 
events. Results: There were no significant differences in heart rate, respiratory rate, and systolic blood pressure among the three 
groups. However, arterial oxygen saturation was significantly reduced in those given 1 mg.kg-1 midazolam. The median scores of 
anxiety, separation from parent, preparing an intravenous line, acceptance of the oxygen mask, good sedation, crying reduction and 
consciousness level were better in midazolam group. Postoperative agitation and re-crying were also more frequent in placebo receivers. 
Those given 1 mg.kg-1 midazolam were significantly more optimal for sedation, crying, consciousness, preparing an intravenous line, 
and postoperative re-crying compared with 0.5 mg.kg-1 midazolam receivers. Conclusion: As a preanaesthetic medication, the 1 mg.kg-1 
dose of orally given midazolam especially in a volume of orange juice and can optimize the children’s behavior during skin laser 
treatment with no serious adverse effects, enhancing their parents’ satisfactions about the sedative protocol. 
Key words: Midazolam. Premedication. Anesthesia. Laser Therapy. Skin.
RESUMO
Objetivo: Investigar e comparar a eficácia do uso oral de midazolam com duas diferentes doses de suco de laranja na hemodinâmica 
peropeatória e mudanças de desempenho em crianças submetidas tratamento de pele por laser em Hospital educacional e acadêmico. 
Métodos: Noventa crianças candidatas a tratamento de pele por laser foram distribuídas aleatóriamente em três grupos de 30 cada: o 
grupo placebo recebeu 0.1mg/kg de suco de laranja, grupos dois e três receberam 0.5 e 1mg/kg de midazolam injetável misturado em 
igual volume de suco de laranja respectivamente. Os principais registros incluíam a aceitação da máscara, escalas de comportamento e 
eventos pós-operatórios. Resultados: Não houve diferenças significantes cardíacas, respiratórias e pressão sanguinea sistólica nos três 
grupos. Contudo, o nível de saturação de oxigênio foi reduzido significantemente nos que receberam 1mg.kg-1 de midazolam.
Os níveis médios de ansiedade, separação dos pais, preparo intravenoso, aceitação da máscara de oxigênio, boa sedação, redução do 
choro e nível de consciência, foram melhores no grupo midazolam. Agitação pós-operatória e retorno do chora foi mais freqüente nos 
que receberam placebo. Observou-se que o grupo que recebeu 1mg.kg-1  foi melhor comparado ao que recebeu  0.5mg.kg-1. Conclusão: 
Como medicação pré-anestésica na dose de 1mg.kg-1 de midazolam, fornecida em igual volume de suco de laranja, é satisfatória no 
comportamento de crianças durante tratamento de pele por laser, proporcionando satisfação dos pais.
Descritores: Midazolam. Pré-Medicação. Anestesia. Terapia a Laser. Pele.
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Introduction 
Preoperative adequate preparation of children can lead to 
improved surgical experiences and faster recovery after surgery. 
This protocol helps the children feel less anxious about the 
anesthesia induction and surgery and can reduce the post-surgical 
complications and maladaptive behavioral changes1,2. Thus, 
in order to minimize the crying and struggling prior to surgery 
and during induction of anesthesia, pre-anesthetic medication is 
recommended for children who are candidates for surgery3.  
Despite a number of pre-medications being advocated 
to facilitate the separation of children from their parents and to 
reduce the anxiety associated with the operation, no choice pre-
medication has universal acceptance. In spite of the rare side 
effects such as respiratory depression, midazolam has become a 
commonly used agent for conscious sedation of children before 
diagnostic or therapeutic procedures or before induction of 
anesthesia. Until recently, only the intravenous form of the drug 
was available. However, it has been clear that the oral midazolam 
is very bitter even with added flavoring. The liquid form of drug 
has been shown to be an extremely safe premedicant for children 
with a dose range of 0.25 to1.0 mg/kg4,5. 
Some studies showed that the premedication with 
midazolam could reduce pre-operative distress and facilitate 
patient management6-8. However, the effects of oral midazolam 
especially mixed with orange juice on hemodynamic status, anxiety 
level and behavioral changes of children after operation has not 
been clearly determined. We tried to investigate and compare the 
efficacy of oral midazolam with the different dosages and mixed 
with orange juice on both postoperative behavioral changes and 
hemodynamics in children who underwent skin laser treatment. 
Methods 
In a randomized, prospective double-blind placebo 
controlled study, 90 children between the ages of two and eight 
years with ASA I-II status presenting for under-anesthesia skin 
laser therapy were included the study. The study protocol was 
explained to the parents and informed consent was obtained from 
them before beginning the study. The study was approved by 
the Ethics Committee in Tehran University of medical sciences. 
Additionally, it conforms to the principles in the Helsinki 
Declaration.
The subjects with the hypersensitivity to benzodiazepines 
and who were treated with drugs that affect the nervous system 
were excluded. Study patients were randomly assigned to one of 
the three groups: 1) the placebo group (as control group) received 
0.1 ml/kg orange flavored juice; 2 and 3) the midazolam groups, 
received injectable midazolam 0.5 mg/kg and 1 mg/kg in an equal 
volume of the orange juice, respectively. The placebo group 
was received the similar preparation. The research physician 
prepared the placebo or midazolam glasses labeled multi-care A, 
B or C to prescribe for the children. The children, their parents 
and the research anesthetist who assessed hemodynamics and 
behavioral changes preoperatively, were blinded to drug and 
placebo assignment. Random allocation was performed by using 
a randomized six-block order of A, B and C.  All children were 
separated from their parents entered the operating room 30 min 
after the oral administration of placebo or midazolam containing 
orange juice. 
Hemodynamic parameters (heart rate, respiratory rate, 
systolic blood pressure, and arterial oxygen saturation) were 
recorded immediately before the entry to operation room and 
also 5, 20, 25, 30, and 40 minutes after the beginning of laser 
therapy. A blinded observer (same observer for all patients) 
scored the patient’s behavior during the perioperative period by 
using the scales assessing the level of anxiety, separation from 
parent, preparing an intravenous line, acceptance of the drug 
administration, acceptance of the oxygen mask, sedation, crying, 
and consciousness. A higher score on these scales indicates a better 
situation (Table 1). 
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Furthermore, postoperative events were recorded for 
each patient. They were a need to airway, nausea and vomiting, re-
crying, abnormal movement, and restless. At the time of discharge 
from the recovery, the parents were asked to rate their satisfaction 
with the pre-medication on a visual analogue scale from 0 to 10 
(0= extremely dissatisfied; 10= extremely satisfied).
Results were reported as mean±S.D. for the quantitative 
variables and percentages for the categorical variables. Non-
parametric and ordinal variables were presented by median (1st, 
3rd quartiles). For the difference of distribution of the scales, 
the groups were compared using the Kruskal- Wallis’ test and 
differences between two treatments groups were analysed with 
Mann–Whitney’s U-test. P values of 0.05 or less were considered 
statistically significant. For multiple comparisons, P values of 
0.01 or less were considered statistically significant after the 
Bonferroni’s correction. All the statistical analyses were performed 
using Statistical Package for Social Sciences version 16 (SPSS 
Inc., Chicago, IL, USA). 
Results 
The patients in the three treatment groups were not 
significantly different with regard to age and sex, but they had 
a different distribution of weight. There were no significant 
differences in heart rate, respiratory rate, and systolic blood 
pressure at any time before and during the operation (0, 5, 20, 
25, 30, and 40 min). However, arterial oxygen saturation was 
significantly lower in those premedicated with 1 mg.kg-1 oral 




1 Excessive/vocal display of fear/apprehension 
2 Moderate/expresses fear/apprehension 
3 Little/minimal expression of fear
4 None
Separation Score:
1 Poor: need for restraint 
2 Fair: separated without crying 
3 Good: separated without crying
4 Excellent: happily separated
Preparing an intravenous 
line
1 Impossibility of IV preparing
2
Possibility of IV preparing in spite of 
child crying
3
Possibility of IV preparing with mild 
resistance
4 Possibility of IV preparing without any resistance
Acceptance Score 
(palatability):
1 Refuses to open mouth after tasting 
2 Held down/forced to accept 




2 Awake/calm & quiet 
3 Drowsy/readily responds
4 Asleep/not readily arousable
Crying severity: 
1 Hysteric crying
2 Severe and continuous crying







4 Complete awake 
TABLE 1 - Behavior scales.
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Placebo Midazolam(0.5mg/kg) Midazolam(1mg/kg) P value 
Male gender 50.0 56.7 46.7 0.733
Age (year) 4.7±1.7 5.1±1.4 4.4±1.5 0.246
Weight (kg) 22.3±3.4 19.1±3.5 21.0±2.9 0.002
Heart rate (beat per min)
0 min 103.5 (95.0, 116.5) 103.0 (96.0, 114.2) 101.5 (93.0, 119.5) 0.999
5 min 114.5 (106.0, 127.5) 114.0 (107.0, 125.2) 112.5 (104.0, 130.0) 0.996
20 min 119.5 (111.0, 132.5) 119.0 (112.0, 128.2) 117.5 (109.0, 134.2) 0.964
25 min 124.5 (116.0, 137.5) 123.5 (117.0, 131.2) 122.5 (114.0, 135.0) 0.826
30 min 122.5 (114.0, 135.5) 121.5 (115.0, 131.2) 120.5 (112.0, 134.7) 0.906
40 min 130.5 (122.0, 143.5) 128.5 (122.7, 136.0) 127.0 (120.0, 136.2) 0.434
Respiratory rate (per min)
0 min 23.0 (20.0, 25.0) 23.0 (20.0, 25.0) 22.5 (19.7, 23.0) 0.767
5 min 24.0 (22.0, 25.2) 24.0 (22.0, 26.0) 24.0 (21.7, 25.0) 0.527
20 min 24.0 (22.0, 25.2) 24.0 (22.0, 26.0) 24.0 (22.0, 25.0) 0.901
25 min 25.0 (23.0, 25.0) 25.0 (23.0, 25.0) 24.0 (23.0, 25.0) 0.724
30 min 25.0 (24.0, 25.2) 25.0 (24.0, 26.0) 25.0 (24.0, 25.0) 0.830
40 min 24.0 (21.0, 25.0) 22.0 (20.0, 24.2) 22.5 (21.0, 25.0) 0.466
Systolic blood pressure (mmHg)
0 min 96.0 (83.7, 99.0) 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 0.019
5 min 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 0.986
20 min 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 0.986
25 min 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 0.986
30 min 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 98.0 (97.0, 99.0) 0.986




0 min 99.0 (97.7, 99.0) 99.0 (98.0, 99.0) 97.0 (97.0, 98.0) <0.001
5 min 98.0 (97.0, 98.2) 98.0 (97.0, 98.2) 97.0 (97.0, 98.0) 0.189
20 min 98.0 (97.0, 98.2) 98.0 (98.0, 98.2) 97.0 (96.7, 98.0) 0.012
25 min 98.0 (97.7, 98.0) 98.0 (98.0, 98.0) 97.0 (96.7, 98.0) 0.031
30 min 98.0 (98.0, 99.0) 98.0 (98.0, 99.0) 97.0 (96.7, 98.0) 0.001
40 min 99.0 (98.0, 99.0) 99.0 (98.0, 99.0) 97.0 (96.7, 99.0) 0.002
The willing acceptance of the drug administration was 
similar between the three groups. The median scores of anxiety, 
separation from parent, preparing an intravenous line, acceptance of 
the oxygen mask, good sedation, crying reduction, consciousness, 
postoperative agitation and re-crying level were better in 
midazolam groups compared with placebo group (P<0.001). The 
children premedicated with 1 mg.kg-1 midazolam were sedated 
better than those with 0.5 mg.kg-1 midazolam (P<0.01). Also, the 
1 mg.kg-1 midazolam group had more optimal level for crying, 
consciousness, preparing an intravenous line compared with other 
premedicated group (P<0.001) (Table 3). 
TABLE 2 - Demographic and hemodynamic data of children allocated to receive midazolam or placebo.
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premedicated group (P<0.001) (Table 3). 
TABLE 3 - Data of behavioral scores of children allocated to receive with midazolam or placebo.
I Kruskal-Wallis statistically significant between three group, P<0.001
II Mann-Whitney U statistically significant between the midazolam 
groups, P<0.01
Adverse events after the operation in the three groups are shown in Table 4. 
TABLE 4 - Adverse events after the operation in children randomly allocated to receive premedication with midazolam or 
placebo.
Placebo Midazolam(0.5mg/kg) Midazolam(1mg/kg)
Anxiety level 2.0 (1.0, 2.2) 2.5 (2.0, 3.0) 3.0 (2.0, 4.0) I
Separation from parent 1.0 (1.0, 1.0) 3.0 (2.0, 3.0) 3.0 (2.0, 3.0) I
Preparing an intravenous line 1.0 (1.0, 1.0) 1.5 (1.0, 2.0) 3.0 (2.0, 3.0) I,II
Acceptance of the drug administration 2.0 (1.0, 3.2) 3.0 (2.0, 4.0) 2.0 (1.0, 3.0) 
Acceptance of the oxygen mask 1.0 (1.0, 3.0) 3.0 (2.0, 3.0) 3.0 (2.0, 3.0) I
Sedation score 1.0 (1.0, 2.0) 2.0 (1.7, 3.0) 3.0 (2.0, 3.0) I,II
Crying severity 1.0 (1.0, 1.0) 2.0 (2.0, 3.0) 3.0 (2.0, 3.0) I,II
Consciousness 1.0 (1.0, 1.0) 1.0 (1.0, 2.0) 3.0 (2.0, 3.0) I,II
Placebo Midazolam (0.5 mg/kg) Midazolam (1 mg/kg)
Need to airway 6.7 10.0 10.0
Nausea and vomiting 3.3 10.0 13.3
Re-crying 86.7 66.7 26.7 I,II
Abnormal movement 10.0 13.3 6.7
Restless (agitation) 76.7 36.7 20.0 I
I Chi-square statistically significant between three group, P<0.001
II Chi-square statistically significant between the midazolam groups, 
P<0.01
Postoperative assessment showed that an increased 
incidence of agitation and re-crying in placebo group compared 
with midazolam premedicated groups (P<0.001). In 1 mg.kg-1 
midazolam group the incidence of postoperative re-crying was 
comparable with 0.5 mg.kg-1 midazolam receivers (P=0.002). 
Discussion  
Several medications are used to relax and calm patients 
specially children before certain procedures or before anesthesia 
for surgery that can help decrease memory of the events. However, 
clinical studies have confirmed some serious complications during 
the post- anesthetic period and child’s discharge time in the use 
of these medications. Thus, the selection of the most effective 
preoperative sedation can accompanied with a trend towards 
better recovery from anesthesia and a higher degree of parental 
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satisfaction. 
In the present study, we investigated the effects of the 
administration of orange juice with and without midazolam on 
children behavioral changes, their parents’ satisfaction and the 
changes of hemodynamics after juice drinking. We firstly found 
that the increase of midazolam dosages led to the child’s better 
behaviors and parent’s satisfaction. Several studies revealed 
similar results, however in their studies, different dosages of oral 
midazolam were applied. Cote et al.9 found that the oral midazolam 
juice was effective for producing sedation and anxiolysis at a dose 
of 0.25 mg.kg-1 and this dosage was led to the minimal effects 
on respiration and oxygen saturation. In a study by Cox et al.10, 
oral midazolam premedication in children was found to reduce the 
anxiety associated with separation from parents with midazolam 0.5 
mg.kg-1 administered 20 to 30 min preoperatively. Also, in another 
study by Kuganeswaran et al.11, medicated patients reported less 
pain and anxiety and physicians observed less pain and anxiety 
compared with placebo during the procedure. Furthermore, in a 
study by Liacouras et al.12, a significant difference was noted in 
the group that was administered oral midazolam for the level of 
sedation for intravenous placement, pre-procedural sedation, ease 
of intravenous insertion, ease of separation from parents, and ease 
of the nursing personnel’s ability to monitor the patient during the 
procedure. These results have been also shown in McErlean et 
al.13, McGraw et al.14, Pandit et al.15 and Cray et al.16 and studies. 
Similar to our study, the positive relationship between the dosage 
of administered midazolam and reduction of abnormal behavioral 
changes was noted in some studies. In a study by Marshall et al.17, 
a significant linear relationship between plasma drug concentration 
and maximal sedation score, but not anxiety score, was observed 
and concluded that the sedative effects were related to plasma 
concentrations of midazolam and the primary metabolite, alpha-
hydroxymidazolam. They confirmed that oral midazolam with the 
dose of 1.0 mg.kg-1, administered within 30 min of the expected 
procedure or anesthetic induction should provide safe and effective 
sedation for a majority of children. In Masue et al.18 study, infants 
and children premedicated with oral midazolam 1.5mg.kg-1 were 
better sedated than those with a standard dose of midazolam. Also, 
in their study, most of infants and children given 1.5 mg.kg-1 of 
midazolam achieved satisfactory sedation in 30 min, in comparison 
with those given 1.0 or 0.5 mg.kg-1. Besides, in some other studies, 
different effect of oral midazolam in sedation of children who were 
candidates for surgery was not proven. In a study by Fine et al.19, 
no differences in resistance, success of delivery, problems with 
separation and mask acceptance were found. Also, Kain et al.20 
indicated that although midazolam was an effective anxiolytic for 
most children, 14.1% of children still exhibit extreme distress. In 
addition, in Kapur et al.21 study, there was no significant difference 
in the acceptability of the test solutions in the children who received 
0.5 mg.kg-1 midazolam mixed in strawberry juice via the oral-
transmucosal route and those in control group were given the same 
juice diluted with normal saline. It seems that the bioavailability 
of midazolam in the commercial preparation was surprisingly 
appropriate and the results were consistently acceptable. However 
this favorable result can be dependant to the different dosages 
of drug so that the recommended dose for children is a single 
dose of 0.25 to 0.5 mg.kg-1 to a maximum dose of 20 mg. Also, 
good outcome of oral midazolam administration in children can 
be related to the children age, obesity, level of basal anxiety, and 
medical need22. Thus, more studies with greater sample sizes are 
needed to determine the best dosages of midazolam to treat the 
children with variant demographic characteristics.  
In our study, except for the reduction of O2 saturation in 
patients received higher dosage of midazolam, other hemodynamics 
were not different between the three groups. Similarly, in study 
by Fine et al.19 arterial oxygen saturation and heart rate were 
not significant changed after the administration of 0.5 mg.kg-1 
oral midazolam. In another study by Masue et al.18 Midazolam 
1.5 mg.kg-1 did not cause any statistically significant decrease in 
blood pressure, arterial oxygen saturation and heart rate. However, 
in Wan et al.23 study, heart rate and systolic blood pressure in 
intervention group who received 0.5 mg.kg-1 of midazolam were 
much lower than that in control group. These results can indicated 
that the changes of vital signs are not only dependant to the 
dosage of oral midazolam and other variables such as the type of 
operation and other patients variables can predict these changes 
that should be considered in further ingestigations. Midazolam 
has a bitter taste that is difficult to disguise even when given in a 
mixture with grape juice24. Whereas, we observed that acceptance 
rate to swallow was similar in placebo or midazolam group. In 
other word, children judged the taste of oral midazolam mixed 
with orange juice not to be different from orange juice alone. 
Conclusions
In conclusion, our data suggest that in spite of some 
complications of midazolam premedication such as reduction 
of arterial O2 saturation, the administration of 1 mg.kg
-1 dosage 
oral midazolam especially in volume of the orange juice can 
significantly reduce children anxiety and agitation for operation. 
As midazolam premedication optimized effectively the children’s 
behavior, it will enhance their parents’ satisfactions about this 
Acta Cirúrgica Brasileira - Vol. 26 (4) 2011 - 309
Perioperative effects of oral midazolam premedication in children undergoing skin laser treatment. 
A double-blinded randomized placebo-controlled trial
sedative protocol. After midazolam medicatiom, the more oxygen 
supplement may be applied during operation to resolve the blood 
oxygen saturation. 
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